Marie Hvelplund Kristiansen

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)Aboriginal and Torres Strait Islander and disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 18, 2025
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms.

Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler

|Jul 23, 2025
Prevalence and impact of additional CHIP mutations in JAK2V617F-positive ischaemic cerebrovascular patients.

Marie Hvelplund Kristiansen, Vibe Skov, Morten Kranker Larsen

|Dec 22, 2023
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidities.

Hans Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjær

|Jul 31, 2023
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study.

Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov

|May 16, 2018
Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea.

M Hvelplund Kristiansen, A M Banghøj, E Laugesen

Pageof 1